Titre :
  • Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion.
Auteur : Burris, Howard A ; Awada, Ahmad ; Kuhn, Josée ; Eckardt, J R ; Cobb, P W ; Rinaldi, D A ; Fields, S ; Smith, L ; Von Hoff, D D
Informations sur la publication : Anti-cancer drugs, 5, 4, (page 394-402)
Statut de publication : Publié, 1994-08
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antineoplastic Agents -- adverse effects
Antineoplastic Agents -- pharmacokinetics
Antineoplastic Agents -- therapeutic use
Camptothecin -- adverse effects
Camptothecin -- analogs & derivatives
Camptothecin -- pharmacokinetics
Camptothecin -- therapeutic use
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Neoplasms -- drug therapy
Neoplasms -- metabolism
Topotecan
Note : Clinical Trial
Clinical Trial, Phase I
Journal Article
Langue :
  • Anglais
Identificateurs : urn:issn:0959-4973 
info:pmid/7949242